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Systolic functionAbstract Introduction: Right ventricular (RV) systolic dysfunction occurs early before clinical
systemic congestion in patients with mitral stenosis (MS). Conventional echocardiographic tech-
niques have some limitations in the assessment of RV function.
Aim of the work: To evaluate the role of two dimensional (2D) longitudinal systolic strain and
strain rate imaging in detection of subclinical RV systolic dysfunction in patients with moderate-
severe MS.
Patients and methods: Fifty patients with isolated MS (moderate-severe) and 30 healthy control
subjects constituted the study population. Conventional echocardiography, pulsed wave tissue
Doppler imaging (TDI) of the tricuspid annulus and 2D longitudinal segmental and global RV sys-
tolic strain (RV-GLS) and strain rate (RV-GLSr) measurements were obtained.
Results: Patients with MS had signiﬁcantly lower RV-GLS and RV-GLSr compared to control
subjects (19.67 ± 6.23 vs. 24.19 ± 3.25, P< 0.001, and 1.49 ± 0.87 vs. 1.91 ± 0.56,
P= 0.02, respectively).
Conclusion: Patients with MS had signiﬁcantly lower 2D RV-GLS and RV-GLSr compared to
control group. 2D RV-GLS and RV-GLSr imaging appear to be useful in detection of subclinical
RV systolic dysfunction in patients with MS.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.1. Introduction
In patients with mitral stenosis (MS), right ventricular (RV)
systolic function is a major determinant of prognosis and sur-
vival. RV systolic dysfunction occurs early before clinical sys-
temic congestion. For this reason, detecting RV failure earlier
is of particular importance.1Echocardiographic assessment of RV function is challeng-
ing due to complex anatomy of RV, narrow acoustic window,
and geometric assumption in volumetric calculations.2
Tissue Doppler imaging (TDI) has signiﬁcant drawbacks,
such as angle dependency, low spatial resolution and analysis
in only one dimension.3
Two-dimensional (2D) strain (S) and strain rate (Sr) imag-
ing enables angle independence and 2D assessment of RV
function and it has been shown in many studies that 2D strain
48 H. Younanimaging is better than conventional Doppler and TDI in the
determination of RV function.4,5
2. Aim of the work
To evaluate the role of 2D longitudinal systolic strain and
strain rate imaging in detection of subclinical RV systolic
dysfunction in patients with moderate-severe MS.
2.1. Patients and methods
The study subjects consisted of 50 patients with established
diagnosis of MS (40 women and 10 men, mean age:
32 ± 8 years) and 30 age-matched healthy individuals (24
women and 6 men, mean age: 34 ± 7 years). The study was
approved by the ethics committee of the hospital and all
included subjects have consented to be enrolled in this study.
2.1.1. Inclusion criteria
Patients with severe rheumatic mitral stenosis who had past
history of rheumatic fever and met the world heart federation
criteria for diagnosis of rheumatic mitral stenosis: Anterior
mitral valve leaﬂet thickening P3 mm, chordal thickening,
restricted leaﬂet motion and excessive leaﬂet tip motion during
systole.6
2.1.2. Exclusion criteria
1. Patients with moderate-severe mitral regurgitation, aortic
stenosis and aortic regurgitation.
2. Patients with any grade of pulmonary and tricuspid valve
stenosis.
3. Patients with LV systolic dysfunction (EF%< 50%).
4. Patients with cardiac rhythm or conduction disturbances
such as atrial ﬁbrillation, bundle branch block and artiﬁcial
pacing.
5. Patients with coronary artery disease.
Each person included in the study was subjected to:
1. Careful history taking and thorough physical examination.
2. Standard twelve-lead electrocardiogram: For assessment of
cardiac rhythm and features suggesting chamber enlarge-
ment and CAD.
3. Basic echocardiographic measurements: Echocardiography
was performed using an Aplio 400, Toshiba, Japan ultraso-
nographic machine with an M4S transducer. Patients were
monitored through a single-lead electrocardiogram. The left
atrial diameter, left ventricular end-systolic and end-dia-
stolic diameters, left ventricular fractional shortening per-
centage, the thickness of the interventricular septum (IVS),
and the posterior wall (PW) were measured according to
the recommendations of the American Society of Echocar-
diography.7 The LV ejection fraction was calculated by
Simpson’s biplane method of disks. Conventional MS indi-
ces, such as maximum mitral valve pressure gradient (PG)
and mean mitral valve pressure gradient (MG) were calcu-
lated. Mitral valve area (MVA) was measured by mitral ori-
ﬁce planimetry in parasternal short axis view, and by the
Doppler derived pressure halftime method (PHT) and theaverage area was calculated by the mean value of two mea-
surements. MS severity was calculated based on hemody-
namic data, using MVA, MG and pulmonary artery
systolic pressure (PASP) as follows: mild MS
(MVA> 1.5 cm2, MG< 5 mmHg, or PAP < 30 mmHg),
moderate MS (MVA 1.0–1.5 cm2, MG 5–10 mmHg, or
PAP 30–50 mmHg), and severe MS (MVA< 1.0 cm2,
MG> 10 mmHg, or PAP > 50 mmHg).PASP was mea-
sured by adding 10 mmHg, considering the diameter of
the inferior vena cava and level of its collapse resulting from
respiration, to the value measured by evaluating Bernoulli
equation, which is simpliﬁed from tricuspid insufﬁciency
velocities. Values of PASPP 35 mmHg deﬁned pulmonary
hypertension.8
4. Detailed echocardiographic assessment of the RV by:
 RV fractional area change (RVFAC%): RV end-dia-
stolic (RVEDA) and end-systolic (RVESA) areas were
measured from the apical 4-chamber (4C) view to calcu-
late RVFAC% as (RVEDA  RVESA)/RVEDA · 100
as shown in Fig. 1.
 Tricuspid annular plane systolic excursion (TAPSE,
mm) was measured in M-mode, using M-mode cursor
in apical 4C view, at the junction of the anterior leaﬂet
of the tricuspid valve with the RV free wall. Maximum
displacement during systole was evaluated and averaged
over three consecutive beats as shown in Fig. 2.
 Pulsed wave tissue Doppler imaging (TDI) of lateral tri-
cuspid annulus velocities: Guided by the 2D apical 4C
view, a 5-mm sample volume was placed on the lateral tri-
cuspid annulus at the place of attachment of the anterior
leaﬂet of the tricuspid valve with theRV free wall formea-
suring tricuspid annular peak systolic velocity (Sm), early
diastolic velocity (Em) and late diastolic velocity and
averaged over three consecutive beats as shown in Fig. 2.
 Two Dimensional strain and strain rate imaging of the
RV: 2D echocardiography images (transmit/receive 1.9/
4.0 MHz) were obtained from the apical 4C view with
frame rates of 50–90 frames/s. Digital data were stored
and analyzed off-line. RV endocardial surface was traced
manually, and the speckle tracking width was modiﬁed
so as to cover the whole RV wall thickness to obtain
curves. The RV free wall and interventricular septum
were divided into three segments, basal, mid, and apical,
for quantiﬁcation of regional systolic strain and strain
rate. Right ventricular global longitudinal systolic strain
(RV-GLS) and right ventricular global longitudinal sys-
tolic strain rate (RV-GLSr) were calculated by averaging
values measured for all 6 segments as shown in Fig. 3.
All the echocardiographic studies were performed by one
cardiologist. Intra-observer variability in RV-GLS and RV-
GLSr was calculated in a sample of 20 randomly selected indi-
viduals. For the analyses of variability, we calculated an
adjusted coefﬁcient of variation, deﬁned as the ratio of the
standard deviation and the mean absolute readings and
intra-class correlation coefﬁcient for RV-GLS and RV-GLSr.
2.2. Statistical analysis
Collected data were computerized and analyzed using Statisti-
cal Package for Social Science (SPSS) version 16. Quantitative
variables were expressed as mean ± standard deviation (SD).
Figure 1 Measurements of RVFAC% derived from RVEDA (Left) and RVESA (Right).
Figure 2 Measurement of TAPSE (Left) and pulsed wave TDI of the lateral tricuspid annulus (Right).
Figure 3 Measurement of 2D-RV global and segmental strain (left) and 2D-RV global strain rate (right) in normal subject.
Subclinical right ventricular systolic dysfunction detection in mitral stenosis patients 49Student’s t-test was used to compare the normally distributed
continuous variable between patients with MS and the healthycontrol group. P values < 0.05 were considered statistically
signiﬁcant.
Table 2 Right Ventricular 2D echocardiographic parameters.
Control MS p value
RVEDD (cm) 2.34 ± 0.42 3.12 ± 0.51 <0.001
RVESD (cm) 1.15 ± 0.18 2.17 ± 0.23 <0.001
RVEDA, cm2 12.3 ± 5.2 15.4 ± 4.6 0.006
RVESA, cm2 5.7 ± 1.7 9.8 ± 1.8 <0.001
RVFAC (%) 52.8 ± 9.3 30.7 ± 5.7 <0.001
TAPSE 2.4 ± 0.2 1.7 ± 0.5 <0.001
RVEDD, right ventricular end-diastolic diameter; RVESD, right
ventricular end-systolic diameter; RVEDA, right ventricular end
diastolic area; RVESA, right ventricular end systolic area;
RVFAC%, right ventricular fractional area change; TAPSE, tri-
cuspid annular plane systolic excursion.
Table 3 Right Ventricular Conventional Doppler and TDI
parameters.
Control MS p value
PASP (mmHg) 22.45 ± 5.70 51.40 ± 11.30 <0.001
Sm (cm/s) 10.22 ± 1.68 8.32 ± 2.12 <0.001
Em (cm/s) 8.29 ± 4.12 8.22 ± 3.54 0.93
Am (cm/s) 8.15 ± 2.23 7.92 ± 1.12 0.54
PASP, pulmonary artery systolic pressure; Sm, tricuspid annular
peak systolic velocity; Em, tricuspid annular peak early diastolic
velocity; Am, tricuspid annular peak late diastolic velocity.
50 H. Younan3. Results
3.1. Demographic and conventional echocardiographic
characteristic
Age and gender indices were similar in control group and
patients with MS (p> 0.05), heart rate was signiﬁcantly higher
in patients with MS compared to control group (p< 0.001).
There was no signiﬁcant difference between systolic and dia-
stolic blood pressure in patients with MS compared to control
group (p> 0.05). There was no signiﬁcant difference in IVS
and PW thickness, LVESD, LVEDD, LVESV, LVEDV,
EF% and FS% in patients with MS compared to control
group (p> 0.05), LA diameter was signiﬁcantly increased in
patients with MS compared to control group (<0.001). Trans-
mitral PG was 21.2 ± 5.4 mmHg, transmitral MG was
10.6 ± 3.8 mmHg and mean MVA was 0.98 ± 0.23 cm2 in
patients with MS as shown in Table 1.
3.2. Right Ventricular 2D echocardiographic parameters
Patients with MS had larger RVEDD (3.12 ± 0.51 vs.
2.34 ± 0.42, p< 0.001), RVESD (2.17 ± 0.23 vs.
1.15 ± 0.18, p< 0.001), RVEDA (15.4 ± 4.6 vs. 12.3 ± 5.2,
p= 0.006), and RVESA (9.8 ± 1.8 vs. 5.7 ± 1.7, p< 0.001);
lower RVFAC% (30.7 ± 5.7 vs. 52.8 ± 9.3, p< 0.001) and
TAPSE (1.7 ± 0.5 vs. 2.4 ± 0.2, p< 0.001) compared to con-
trol subjects as shown in Table 2.
3.3. Right ventricular conventional Doppler and TDI parameters
Patients with MS had higher PASP compared to control sub-
jects (51.40 ± 11.30 vs. 22.45 ± 5.70, P< 0.001). The mean
Sm velocity was signiﬁcantly lower in patients with MS com-
pared to control subjects (8.32 ± 2.12 cm/s vs.
10.22 ± 1.68 cm/s, P< 0.001). There were no signiﬁcant dif-
ferences in Em (8.22 ± 3.54 vs. 8.29 ± 4.12, P= 0.93) andTable 1 Clinical and echocardiographic features of the study group
Control
Age, years 34 ± 7
Female/male 24 / 6
Heart Rate, bpm 67 ± 6
SBP, mmHg 121 ± 9
DBP, mmHg 82 ± 6
IVS thickness, cm 0.82 ± 0.09
PWT, cm 0.83 ± 0.08
LV end-diastolic diameter, cm 4.86 ± 0.32
LV end-systolic diameter, cm 3.25 ± 0.29
LV end-diastolic volume, ml 104 ± 21
LV end-systolic volume, ml 36 ± 9
EF, % 63 ± 4
FS, % 33 ± 5
LA diameter, cm 3.41 ± 0.35
MVA, cm2 –
Mitral Valve PG, mmHg –
Mitral Valve MG, mmHg –
SBP, systolic blood pressure; DBP, diastolic blood pressure; IVS, interv
ventricle; EF; ejection fraction, FS, fractional shortening; LA, left atri
transmitral mean gradient.Am velocities (7.92 ± 1.12 vs. 8.15 ± 2.23, P= 0.54) between
patients with MS and control subjects as shown in Table 3.
3.4. Right ventricular systolic strain and strain rate parameters
RV-GLS and RV-GLSr were signiﬁcantly reduced in patients
with MS compared to control subjects (19.67 ± 6.23 vs.
24.19 ± 3.25, P< 0.001, and 1.49 ± 0.87 vs.
1.91 ± 0.56, P= 0.02 respectively) as shown in Table 4.s.
MS p value
32 ± 8 0.260
40 / 10 NS
79 ± 12 <0.001
118 ± 7 0.100
79 ± 7 0.054
0.81 ± 0.07 0.580
0.82 ± 0.11 0.665
4.67 ± 0.51 0.070
3.14 ± 0.42 0.220
102 ± 17 0.642
38 ± 11 0.403
62 ± 3 0.200
32 ± 5 0.380
4.72 ± 0.31 <0.001
0.98 ± 0.23 –
21.2 ± 5.4 –
10.6 ± 3.8 –
entricular septum thickness; PWT, posterior wall thickness; LV, left
um; MVA, mitral valve area; PG, transmitral peak gradient; MG,
Table 4 Right ventricular strain and strain rate parameters.
Control MS p value
Basal RV septal S (%) 26.32 ± 4.42 16.07 ± 6.75 <0.001
Mid RV septal S (%) 25.61 ± 3.28 15.98 ± 4.28 <0.001
Apical RV septal S (%) 24.55 ± 3.21 16.21 ± 5.65 <0.001
Basal RVFW S (%) 26.22 ± 2.45 24.65 ± 5.11 0.119
Mid RVFW S (%) 24.18 ± 5.82 22.98 ± 5.29 0.347
Apical RVFW S (%) 23.11 ± 4.25 21.50 ± 3.36 0.064
RV-GLS (%) 24.19 ± 3.25 19.67 ± 6.23 <0.001
Basal RV septal Sr (s1) 2.14 ± 0.55 1.36 ± 0.62 <0.001
Mid RV septal Sr (s1) 1.98 ± 0.26 1.21 ± 0.74 <0.001
Apical RV septal Sr (s1) 1.91 ± 0.79 1.24 ± 0.28 <0.001
Basal RVFW Sr (s1) 1.94 ± 0.68 1.84 ± 0.44 0.426
Mid RVFW Sr (s1) 1.85 ± 0.47 1.77 ± 0.53 0.497
Apical RVFW S (s1) 1.71 ± 0.60 1.65 ± 0.34 0.569
RV-GLSr1 (%) (s1) 1.91 ± 0.56 1.49 ± 0.87 0.020
RV, right ventricle; RVFW, right ventricular free wall; S, systolic strain; RV-GLS, right ventricular global longitudinal systolic strain; Sr,
systolic strain rate; RV-GLSr, right ventricular global longitudinal systolic strain rate.
Table 5 Correlations between RV-GLS and RV-GLSr and
conventional echocardiographic parameters.
RV-GLS (%) RV-GLSSr (S1)
r value p value r value p value
MVA 0.040 0.628 0.010 0.780
MG 0.115 0.402 0.062 0.632
PG 0.233 0.092 0.219 0.160
LA diameter (cm) 0.612 0.002 0.415 0.010
PASP (mmHg) 0.345 0.042 0.172 0.315
RVEDD (cm) 0.051 0.731 0.108 0.487
RVESD (cm) 0.465 0.004 0.085 0.612
RVFAC (%) 0.439 0.005 0.050 0.590
TAPSE 0.514 0.001 0.472 0.004
Sm (cm/s) 0.568 0.001 0.402 0.005
MVA, mitral valve area; PG, transmitral peak gradient; MG,
transmitral mean gradient LA, left atrium; PASP, pulmonary artery
systolic pressure, RVEDD, right ventricular end-diastolic diameter;
RVESD, right ventricular end-systolic diameter; RVFAC, right
ventricular fractional area change; TAPSE, tricuspid annular plane
systolic excursion, Sm, tricuspid annular peak systolic velocity.
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strain at basal RV septum (16.07 ± 6.75 vs.
26.32 ± 4.42; p< 0.001), mid RV septum (15.98 ± 4.28
vs. 25.61 ± 3.28; p< 0.001) and apical RV septum
(16.21 ± 5.65 vs. 24.55 ± 3.21; p< 0.001) in patients with
MS compared to control subjects. There were no signiﬁcant
differences in the regional strain at basal RV free wall
(24.65 ± 5.11 vs. 26.22 ± 2.45; p= 0.119), mid RV free
wall (22.98 ± 5.29 vs. 24.18 ± 5.82; p= 0.347) and apical
RV free wall (21.50 ± 3.36 vs. 23.11 ± 4.25, p= 0.064)
between patients with MS compared to control subjects as
shown in Table 4.
In addition, there was signiﬁcantly lower regional strain
rate at basal RV septum (1.36 ± 0.62 vs. 2.14 ± 0.55;
p< 0.001), mid RV septum (1.21 ± 0.74 vs. 1.98 ± 0.26;
p< 0.001) and apical RV septum (1.24 ± 0.28 vs.
1.91 ± 0.79; p< 0.001) of patients with MS compared to
control subjects. There was no signiﬁcant difference in the
regional strain rate at basal RV free wall (1.84 ± 0.44 vs.
1.94 ± 0.68; p= 0.426), mid RV free wall (1.77 ± 0.53
vs. 1.85 ± 0.47; p= 0.497) and apical RV free wall
(1.65 ± 0.34 vs. 1.71 ± 0.60, p= 0.569) between patients
with MS compared to control subjects as shown in Table 4.
Intra-class correlations for intra-observer variability were
good for RV-GLS (0.93, 95% CI 0.83–0.92); and RV-GLSr
(0.90, 95% CI 0.60–0.96)
3.5. Correlations of RV-GLS and RV-GLSr
Correlation analysis revealed a weak but signiﬁcant negative
correlation between RV-GLS with PASP (r= 0.345,
p= 0.042); moderate negative correlation between RV-GLS
with RVESD (r= 0.465, p= 0.004) and LA diameter
(r= 0.612, p= 0.002); and moderate positive correlation
between RV-GLS and RVFAC (r= 0.439, p= 0.005),
TAPSE (r= 0.514, p= 0.001) and Sm (r= 0.568,
p= 0.001). Correlation analysis also revealed moderate nega-
tive correlation between RV-GLSr and LA diameter
(r= 0.415, p= 0.010); and moderate positive correlation
between RV-GLSr with TAPSE (r= 0.472, p= 0.004) and
Sm (r= 0.402, p= 0.005) as shown in Table 5.4. Discussion
Systolic dysfunction of the right ventricle is well documented
in patients with rheumatic MS.9 RV systolic dysfunction devel-
ops before clinical symptoms appear. For this reason, detect-
ing RV failure earlier is of particular importance.1 2D strain
and strain rate imaging have been recently used in the assess-
ment of RV function.10,11 The longitudinal ﬁbers of the RV
contribute to the systolic function more than the circumferen-
tial ﬁbers,12 consequently; RV-GLS and RV-GLSr are closely
related to the systolic function of RV and can be used in quan-
titative evaluations.
Our results demonstrated signiﬁcantly lower RV-GLS and
RV-GLSr in patients with MS compared to control subjects
(19.67 ± 6.23 vs. 24.19 ± 3.25, P< 0.001, and
1.49 ± 0.87 vs. 1.91 ± 0.56, P= 0.02 respectively). Corre-
lation analysis revealed a weak but signiﬁcant negative correla-
tion between RV-GLS with PASP (r= 0.345, p= 0.042);
52 H. Younanmoderate negative correlation between RV-GLS with RVESD
(r= 0.465, p= 0.004) and LA diameter (r= 0.612,
p= 0.002); and moderate positive correlation between RV-
GLS and RVFAC (r= 0.439, p= 0.005), TAPSE (r= 0.514,
p= 0.001) and Sm (r= 0.568, p= 0.001). Correlation analysis
also revealed moderate negative correlation between RV-GLSr
and LA diameter (r= 0.415, p= 0.010); and moderate posi-
tive correlation between RV-GLSr with TAPSE (r= 0.472,
p= 0.004) and Sm (r= 0.402, p= 0.005).
Our results can be explained by myocardial dysfunction sec-
ondary to direct rheumatic involvement of the RVmyocardium
with resultant myocyte necrosis, replacement ﬁbrosis and calci-
ﬁcation.1,13 Malholtra et al.14 found in their histo-morpholog-
ical study of cases of rheumatic heart disease that intra
myocardial branches of myocardial vessels were also involved
in a form of active rheumatic vasculitis characterized by medial
hypertrophy and replacement ﬁbrosis and they speculated that
these changes might affect myocardial function. Mittal and
Goozar15 found signiﬁcantly impaired RV systolic function in
22 cases of isolated rheumaticMS and did not ﬁnd any relation-
ship between parameters of RV systolic function and PASP and
the authors attributed the impairment of RV systolic function
to myocardial involvement of the rheumatic process. RV sys-
tolic dysfunction has also been reported in all cases of rheu-
matic MS regardless of pulmonary artery pressure16 and long
term follow up of cases with MS, revealed evidence for progres-
sive right heart disease independent ofMS severity.9 Inci et al.17
evaluated RV systolic function before, immediately after, and
at 3 months and 1 year after percutaneous balloon mitral val-
vuloplasty (PBMV) by conventional and TDI imaging methods
and observed no improvement in the RV systolic function
despite the improved hemodynamic status and attributed their
ﬁndings to irreversible myocardial damage due to rheumatic
pathology or long-lasting hemodynamic burden.
Our results were in agreement with those of Yildirimturk
et al.1 who found signiﬁcantly lower mean RV-GLS
(21.6 ± 5.4 vs. 25.4 ± 5.0, P= 0.049) and RV-GLSr
(1.21 ± 0.68 vs. 1.64 ± 0.24, P= 0.038) in patients with
moderate-severe MS compared to control subjects, correlation
analysis revealed signiﬁcant inverse correlation between RV-
GLS and mean transmitral gradient (r= 0.358, P= 0.027)
and PASP (r= 0.586, P< 0.001) and signiﬁcant inverse cor-
relation between RV-GLS and PASP (r= 0.450, P= 0.005)
in patients with MS. Additionally, Castro et al.18 found signiﬁ-
cantly lower mean RV 2D global longitudinal strain in patients
with severe MS compared to healthy subjects (17.5 ± 3.9%
vs. 21.8 ± 3.4%; p= 0.007) and an inverse correlation
between RV-GLS and PASP in patients with MS. A recently
published study by Kumar et al.19 found signiﬁcantly lower
RV-GLS in patients with severe MS compared to control sub-
jects (14.67 ± 3.95 vs. 9.07 ± 4.70; p< 0.02) and an inverse
correlation between RV-GLS and PASP (r= 0.416, p= 0.02).
Signiﬁcantly lower RV strain and strain rate were also
recorded in less severe forms of MS, Tanboga et al.20 evaluated
59 patients with mild-moderate MS and found signiﬁcantly
lower RV-GLS (23.5 ± 7.2 vs. 18.63 ± 6.3, P= 0.001)
and RV-GLSr (1.72 ± 0.54 vs. 1.37 ± 0.66, P= 0.01) in
patients with MS compared to control group and moderate
correlation between RV-GLS, and RV-GLSr with MVA,
TAPSE, RVESD, and PASP. Another study by Ozdemir
et al.21 found signiﬁcantly lower RV global strain in 45patients with mild-moderate MS compared to control group
(20 ± 7 vs. 24 ± 6%, P= 0.02).
Our results revealed signiﬁcantly lower regional strain and
strain rate at basal, mid and apical segments of the RV septum
in patients with MS compared to control subjects. On the
other hand, there was no signiﬁcant difference in strain and
strain rate at basal, mid and apical segments of the RV free
wall of patients in patients with MS compared to control sub-
jects. Our ﬁndings can be explained by the contact of the IVS
with the mitral apparatus through LV ﬁbers, so rheumatic pro-
cess may easily extend to the segments of the IVS and may lead
to a decreased myocardial contraction that is independent of
pulmonary arterial hypertension, on the other hand, the RV
free wall is not affected by the rheumatic process and retains
normal contractile function.
This ﬁnding is concordant with that of Kumar et al.19 who
found signiﬁcantly lower regional strain at basal RV septum
(11.63 ± 6.63 vs. 18.22 ± 9.65; p= 0.02), mid RV septum
(9.31 ± 5.65 vs.18.98 ± 3.25; p= 0.001), apical RV sep-
tum (13.75 ± 5.32 vs. 19.69 ± 6.38; p= 0.005) and basal
RV free wall segment (19.35 ± 14.10 vs. 32.57 ± 14.98;
p= 0.012) in patients with severe MS compared to health sub-
jects. This again is concordant with Ozdemir et al.21 who found
signiﬁcantly lower RV septal strain (19 ± 7 vs. 23 ± 5,
P= 0.03) and strain rate (1.2 ± 0.4 vs. 1.5 ± 0.3,
P= 0.005) and normal RV free wall strain (22 ± 8–
26 ± 9, P> 0.05) and strain rate (1.8 ± 0.5–1.8 ± 0.4,
P> 0.05) in patients with mild-moderate MS compared to
control group. On the other hand, Yildirimturk et al.1 found
signiﬁcantly reduced strain and strain rate at the RV free wall
segments in patients with moderate-severe MS compared to
control group, while the strain and strain rate of the RV septal
wall segments were similar in both groups with a slight trend of
lower values in MS patients, the authors attributed the impair-
ment of RV free wall strain and strain rate to increased RV
afterload and higher wall stress due to ventricular dilatation.5. Conclusion
Patients withMS had lower two dimensional RV-GLS andRV-
GLSr compared to control group. Two dimensional RV systolic
strain and strain rate imaging appear to be useful in detection of
subclinical RV systolic dysfunction in patients with MS.6. Study limitations
Potential limitation of the present study is the relatively small
sample size so the results may not be generalized. As only stan-
dard apical 4C images were obtained, we could only measure
longitudinal strain and strain rate parameters, so neither cir-
cumferential nor radial strain and strain rate analysis could
be carried out. We did not evaluate the RV systolic function
with gold standard modalities like 3D echocardiography and
MRI, so we were unable to compare the results obtained by
echocardiography with different imaging modalities.
7. Recommendations
Further studies with a larger cohort of patients and various
grades of MS are necessary to conﬁrm the results of our study.
Subclinical right ventricular systolic dysfunction detection in mitral stenosis patients 53Also, further studies are required to analyze the effect of
balloon mitral valvuloplasty on global and segmental RV
strain and strain rate.
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